• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Organisation › Details

Bayer Innovation GmbH (BIG)

https://www.bayer-innovation.de
Link has been incorrect on 2014-06-11

Bayer Innovation GmbH (BIG) is based in Düsseldorf and is a wholly owned subsidiary of Bayer AG. BIG evaluates and develops new areas of business for the Bayer Group that tie in with Bayer's core skills of health care, nutrition and high-tech materials and complement the Group's existing focal points in terms of innovation and business strategy. *

 

	Start	2006-01-11 existent
	Group	Bayer (Group)
	Industry	business services
	Region	Düsseldorf
	Country	Germany
	Street	1 Merowinger Platz
	City	40225 Düsseldorf
	Tel	+1-49-211-758458-0
		Address record changed: 2020-12-02
Basic data	Employees	n. a.
		* Document for �About Section�:
		Record changed: 2017-04-01

Advertisement

More documents for Bayer (Group)

• [1] CureVac N.V.. (1/7/21). "Press Release: CureVac and Bayer Join Forces on COVID-19 Vaccine Candidate CVnCoV". Berlin, Tübingen & Boston; MA....
• [2] Bayer AG. (1/6/21). "Press Release: Leaps by Bayer Leads USD 105 Million Series B Financing in Senti Bio to Develop Next-generation Cell and Gene Therapies Using Advanced Gene Circuit Technology Platform". Leverkusen & South San Francisco, CA....
• [3] Veracyte, Inc.. (12/22/20). "Press Release: Bayer and Veracyte Announce Precision Oncology Collaboration in Thyroid Cancer". Whippany, NJ & San Francisco, CA....
• [4] NuCana plc. (12/21/20). "Press Release: NuCana Appoints Andrew Kay as Board Chairman". Edinburgh....
• [5] Bayer AG. (12/6/20). "Press Release: Bayer and Atara Biotherapeutics Enter Strategic Collaboration for Mesothelin-Targeted CAR T-cell Therapies for Solid Tumors". Whippany, NJ & South San Francisco, CA....
• [6] Semalytix GmbH. (11/24/20). "Press Release: Corporate Vice President of Bayer Pharmaceuticals Becomes Advisor to Semalytix". Bielefeld....
• [7] Bayer AG. (11/12/20). "Press Release: Metagenomi Closes USD 65 Million Series A Financing Led by Leaps by Bayer and Humboldt Fund". Emeryville, CA & Leverkusen....
• [8] Bayer AG. (11/9/20). "Press Release: Bayer Submits Marketing Authorization Applications for Finerenone in the U.S. and the EU for Patients with Chronic Kidney Disease and Type 2 Diabetes". Berlin....
• [9] Bayer AG. (10/27/20). "Press Release: Bayer Appoints Dr. Christian Rommel as New Head of Pharmaceuticals Research and Development". Berlin....
• [10] Bayer AG. (10/26/20). "Press Release: Bayer Acquires Asklepios BioPharmaceutical to Broaden Innovation Base in Cell and Gene Therapy". Berlin....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2021. Made in Germany.